mrd: a promising biomarker in multiple myeloma
Published 2 years ago • 71 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
3:00
current & emerging biomarkers in multiple myeloma
-
1:38
using mrd to guide therapy in multiple myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
4:38
the potential of mrd-adapted treatment in multiple myeloma
-
1:05
ultrastratification of multiple myeloma via biomarkers
-
1:59
methods used to assess mrd status in multiple myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
1:37
predictors of unsustained mrd negativity in transplant-eligible patients with multiple myeloma
-
2:55
comy 2023 thank you from mohamad mohty
-
5:37
biomarkers in ultra low-risk myeloma
-
1:20
mrd in myeloma
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
1:37
mrd in myeloma
-
4:16
the prognostic value of mrd in multiple myeloma & mrd-guided therapy
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
8:42
assessing mrd in multiple myeloma
-
4:39
highlights from day 2: mrd in myeloma